Antimycobacterial Activity of Solid Lipid Microparticles Loaded with Ursolic Acid and Oleanolic Acid: In Vitro, In Vivo, and Toxicity Assessments
Authors:
- Vinay SainiVinay Saini
- Dulce Mata EspinosaDEDulce Mata Espinosa
- Alok PandeyAPAlok Pandey
- Vikas DigheVDVikas Dighe
- Jorge Barrios PayánJPJorge Barrios Payán
- Vithal Prasad MyneeduVMVithal Prasad Myneedu
- Ivan Valdez ZarateIZIvan Valdez Zarate
- Dhanji P. RajaniDRDhanji P. Rajani
- Lalit D. AnandeLALalit D. Anande
- Rogelio Hernandez PandoRogelio Hernandez Pando
- Rohit SrivastavaRSRohit Srivastava
Open Access
- 25 October 2024
- journal article
- research article
- Published by MDPI AG in Microorganisms
- Vol. 12 (11) , 2140
Abstract
Ursolic acid (UA) and oleanolic acid (OA) are hydrophobic triterpenoid isomers with demonstrated anti-mycobacterial (Mtb) and immune-regulatory properties, although their poor solubility limits clinical use. We report the development of solid lipid microparticles (SLMs) as delivery vehicles for UA and OA and evaluate their anti-Mtb efficacy in vitro and in vivo, as well as their acute toxicity. SLMs measured 0.7–0.89 µM in size, with complete in vitro release of OA and UA at 40 and 32 h, respectively. The minimum inhibitory concentration (MIC) of SLMs loaded with OA and UA was 40 µg/mL SLMs + 20 µg/mL OA + 20 µg/mL UA for drug-sensitive Mtb and 80 µg/mL SLMs + 40 µg/mL OA + 40 µg/mL UA for multidrug-resistant (MDR) Mtb. These SLMs showed an efficient reduction in Mtb burden in infected alveolar macrophages. In a murine model of late-stage progressive MDR-TB, aerosolized delivery of SLMs containing OA and UA via a metered-dose inhaler significantly reduced pulmonary bacterial loads and extended survival. In vivo, acute toxicity studies revealed no mortality or signs of toxicity. These findings demonstrate that SLMs are an optimal delivery system for terpenoids, providing potent in vitro and in vivo anti-TB activity with an excellent safety profile.Keywords
Funding Information
- Indian Health Fund (RD/0116-TATAE00-001)
- Local Project Support of the National Institute of Medical Sciences and Nutrition Mexico (RD/0116-TATAE00-001)
This publication has 50 references indexed in Scilit:
- Immunomodulatory properties of triterpenesPhytochemistry Reviews, 2021
- Hepatoprotective properties of oleanolic and ursolic acids in antitubercular drug-induced liver damageAsian Pacific Journal of Tropical Medicine, 2016
- The role of triterpenes in the management of diabetes mellitus and its complicationsPhytochemistry Reviews, 2014
- Oleanolic acid and ursolic acid affect peptidoglycan metabolism in Listeria monocytogenesAntonie van Leeuwenhoek, 2009
- Rate-modulating PHBHV/PCL microparticles containing weak acid model drugsInternational Journal of Pharmaceutics, 2007
- Solid lipid microparticles as a sustained release system for pulmonary drug deliveryEuropean Journal of Pharmaceutics and Biopharmaceutics, 2007
- Bactericidal Activity of Organic Extracts from Flourensia cernua DC against Strains of Mycobacterium tuberculosisArchives of Medical Research, 2006
- Secondary Metabolites fromChamaedora tepejilote (Palmae) are Active againstMycobacterium tuberculosisPhytotherapy Research, 2005
- Nitric Oxide and Tumor Necrosis Factor-α Production by Oleanolic Acid via Nuclear Factor-κB Activation in MacrophagesBiochemical and Biophysical Research Communications, 2001
- Pharmacology of oleanolic acid and ursolic acidJournal of Ethnopharmacology, 1995